eMERGE is a national network organized and funded by the
National Human Genome Research Institute (NHGRI) that combines DNA
biorepositories with electronic medical record (EMR) systems for large
scale, high-throughput genetic research in support of implementing genomic
medicine.
Many factors contribute to risk of a disease. Some of these factors are internal,
like genetics, and others are external, like where someone lives. Over the last several years
researchers have discovered that in addition to one gene being associated with a given
disease (monogenic factors), many genes across your genome can contribute to the development
of a disease (polygenic factors). To learn more about elements that contribute to risk a disease,
click here.
Latest News
NHGRI 2025 Training Meeting
December 12, 2024 10:27 PM
Funding Announcement: RFA-HG-25-005
November 11, 2024 2:36 PM
FY25 Bioethics NOSI is Live
October 10, 2024 7:32 PM
NOSI: Administrative supplements to active NIH awards to support replication studies using independent contract resources (NOT-RM-24-013)
October 10, 2024 3:28 PM
2025 HuBMAP Summer Undergraduate Internship Program
October 10, 2024 2:59 PM
Education Outreach Specialist – GS-13 Position
October 10, 2024 2:57 PM
Recent Publications
Fejzo M, Wang X, Zöllner J, Pujol-Gualdo N, Mancuso N, et al. Multi-ancestry GWAS of severe pregnancy nausea and vomiting identifies risk loci associated with appetite, insulin signaling, and brain plasticity. medRxiv : the preprint server for health sciences. 2024 Nov 20;.
Shelley JP, Shi M, Peterson JF, Van Driest SL, Mosley JD. A polygenic score for height identifies an unmeasured genetic predisposition among pediatric patients with idiopathic short stature. Research square. 2024 Oct 14;.
Obare LM, Bailin SS, Zhang X, Nthenge K, Wanjalla CN, et al. HIV persists in late coronary atheroma and is associated with increased local inflammation and disease progression. Research square. 2024 Oct 18;.